163 related articles for article (PubMed ID: 22795534)
1. Evaluation of tyrosine receptor kinases in the interactions of head and neck squamous cell carcinoma cells and fibroblasts.
Sweeny L; Zimmermann TM; Liu Z; Rosenthal EL
Oral Oncol; 2012 Dec; 48(12):1242-9. PubMed ID: 22795534
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of fibroblasts reduced head and neck cancer growth by targeting fibroblast growth factor receptor.
Sweeny L; Liu Z; Lancaster W; Hart J; Hartman YE; Rosenthal EL
Laryngoscope; 2012 Jul; 122(7):1539-44. PubMed ID: 22460537
[TBL] [Abstract][Full Text] [Related]
3. Elevated RET expression enhances EGFR activation and mediates EGFR inhibitor resistance in head and neck squamous cell carcinoma.
Lin C; Lu W; Ren Z; Tang Y; Zhang C; Yang R; Chen Y; Cao W; Wang L; Wang X; Ji T
Cancer Lett; 2016 Jul; 377(1):1-10. PubMed ID: 27090738
[TBL] [Abstract][Full Text] [Related]
4. Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression.
O-Charoenrat P; Rhys-Evans P; Eccles S
Anticancer Res; 2001; 21(3B):1953-63. PubMed ID: 11497283
[TBL] [Abstract][Full Text] [Related]
5. Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.
Prasad R; Katiyar SK
PLoS One; 2012; 7(9):e46404. PubMed ID: 23050025
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of DDR2 contributes to cell invasion and migration in head and neck squamous cell carcinoma.
Xu J; Lu W; Zhang S; Zhu C; Ren T; Zhu T; Zhao H; Liu Y; Su J
Cancer Biol Ther; 2014 May; 15(5):612-22. PubMed ID: 24556606
[TBL] [Abstract][Full Text] [Related]
7. HGF and c-Met participate in paracrine tumorigenic pathways in head and neck squamous cell cancer.
Knowles LM; Stabile LP; Egloff AM; Rothstein ME; Thomas SM; Gubish CT; Lerner EC; Seethala RR; Suzuki S; Quesnelle KM; Morgan S; Ferris RL; Grandis JR; Siegfried JM
Clin Cancer Res; 2009 Jun; 15(11):3740-50. PubMed ID: 19470725
[TBL] [Abstract][Full Text] [Related]
8. Targeting VEGFR and FGFR in head and neck squamous cell carcinoma in vitro.
Brands RC; Knierim LM; De Donno F; Steinacker V; Hartmann S; Seher A; Kübler AC; Müller-Richter UDA
Oncol Rep; 2017 Sep; 38(3):1877-1885. PubMed ID: 28714017
[TBL] [Abstract][Full Text] [Related]
9. A role for p38 MAPK in head and neck cancer cell growth and tumor-induced angiogenesis and lymphangiogenesis.
Leelahavanichkul K; Amornphimoltham P; Molinolo AA; Basile JR; Koontongkaew S; Gutkind JS
Mol Oncol; 2014 Feb; 8(1):105-18. PubMed ID: 24216180
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo.
Zhang W; Matrisian LM; Holmbeck K; Vick CC; Rosenthal EL
BMC Cancer; 2006 Mar; 6():52. PubMed ID: 16515711
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.
Wheeler SE; Shi H; Lin F; Dasari S; Bednash J; Thorne S; Watkins S; Joshi R; Thomas SM
Head Neck; 2014 Mar; 36(3):385-92. PubMed ID: 23728942
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Jun NH2-terminal kinases suppresses the growth of experimental head and neck squamous cell carcinoma.
Gross ND; Boyle JO; Du B; Kekatpure VD; Lantowski A; Thaler HT; Weksler BB; Subbaramaiah K; Dannenberg AJ
Clin Cancer Res; 2007 Oct; 13(19):5910-7. PubMed ID: 17908987
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol selectively induces DNA Damage, independent of Smad4 expression, in its efficacy against human head and neck squamous cell carcinoma.
Tyagi A; Gu M; Takahata T; Frederick B; Agarwal C; Siriwardana S; Agarwal R; Sclafani RA
Clin Cancer Res; 2011 Aug; 17(16):5402-11. PubMed ID: 21705453
[TBL] [Abstract][Full Text] [Related]
14. Anti-lymphangiogenic properties of mTOR inhibitors in head and neck squamous cell carcinoma experimental models.
Ekshyyan O; Moore-Medlin TN; Raley MC; Sonavane K; Rong X; Brodt MA; Abreo F; Alexander JS; Nathan CA
BMC Cancer; 2013 Jul; 13():320. PubMed ID: 23815869
[TBL] [Abstract][Full Text] [Related]
15. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas.
Galeazzi E; Olivero M; Gervasio FC; De Stefani A; Valente G; Comoglio PM; Di Renzo MF; Cortesina G
Eur Arch Otorhinolaryngol; 1997; 254 Suppl 1():S138-43. PubMed ID: 9065649
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of radiation induced migration of human head and neck squamous cell carcinoma cells by blocking of EGF receptor pathways.
Pickhard AC; Margraf J; Knopf A; Stark T; Piontek G; Beck C; Boulesteix AL; Scherer EQ; Pigorsch S; Schlegel J; Arnold W; Reiter R
BMC Cancer; 2011 Sep; 11():388. PubMed ID: 21896192
[TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
[TBL] [Abstract][Full Text] [Related]
19. 7beta-hydroxycholesterol induces apoptosis and regulates cyclooxygenase 2 in head and neck squamous cell carcinoma.
Heiduschka G; Erovic BM; Vormittag L; Skoda C; Martinek H; Brunner M; Ehrenberger K; Thurnher D
Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):261-7. PubMed ID: 19289704
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapeutic alteration of VEGF-/PDGF- and PDGF-Rα/β expression by imatinib in HPV-transformed squamous cell carcinoma compared to HPV-negative HNSCC in vitro.
Schultz JD; Mühlheim K; Erben P; Hofheinz RD; Faber A; Thorn C; Sommer JU; Hörmann K; Sauter A
Oncol Rep; 2011 Nov; 26(5):1099-109. PubMed ID: 21805039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
